Integrative Metabolomics, Pharmacoinformatics and Experimental Studies Reveal the Neuroprotective Potential of Caulerpa racemosa Metabolites Against Alzheimer’s Disease
Marine Drugs · 11.12.2025 · 23 (12) · 475
DOI: 10.3390/md23120475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 11.12.2025. Verfasst von Nita Handayani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Faculty of Science and Technology, Universitas Islam Negeri (UIN) Sunan Kalijaga Yogyakarta, Yogyakarta 55281, Indonesia. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Caulerpa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Penelitian Inovasi Teknologi Program of UIN Sunan Kalijaga Yogyakarta.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by cholinergic dysfunction, oxidative/nitrosative stress, and neuroinflammation. Marine green algae Caulerpa racemosa are rich in neuroactive lipids and fatty acid derivatives with reported antioxidant and anti-inflammatory properties. However, their integrated mechanistic potential against AD remains largely underexplored. This study aimed to elucidate the neuroprotective mechanisms of C. racemosa metabolites against AD using integrative metabolomics, network pharmacology, molecular docking, and in vitro validation assays. Untargeted LC–HRMS profiling was performed to identify major metabolites in the ethanolic extract of C. racemosa. Neuroprotective targets were predicted via TargetNet, STRING, and Cytoscape (MCODE, CytoNCA). Functional enrichment was conducted using KEGG, GO (BP, MF, CC), and ClueGO. Molecular docking (CB-Dock2) validated compound–target interactions with ACHE, CHRM1, NOS1, and NOS2. Antioxidant (DPPH) and cholinesterase (AChE/BChE) inhibitory activities were evaluated in vitro. Metabolomic profiling identified lipid-dominant metabolites—oleamide, hexadecanamide, palmitoyl ethanolamide, α-linolenic acid, α-eleostearic acid, and 9-oxo-octadecadienoic acid. Network analysis revealed key AD-related hubs (ACHE, CHRM1, NOS1, NOS2) enriched in cholinergic regulation, arachidonic-acid metabolism, oxidative stress response, and nitric oxide signaling. Docking showed moderate multi-target affinities (−6.0 to −8.4 kcal/mol), with α-linolenic acid, α-eleostearic acid, and oxidized C18 lipids exhibiting the strongest interactions—particularly with ACHE and NOS isoforms. In vitro assays showed moderate antioxidant activity (IC50 = 120.97 ± 10.93 µg/mL) and cholinesterase inhibition (AChE IC50 = 136.48 ± 1.70 µg/mL; BChE IC50 = 145.98 ± 3.28 µg/mL), aligning with predicted multi-target interactions. C. racemosa extract exhibits neuroprotective potential through a synergistic combination of cholinergic modulation, antioxidant activity, NOS-mediated nitrosative stress reduction, and suppression of arachidonic-acid inflammatory pathways. These findings support C. racemosa as a promising marine-derived multi-target candidate for AD intervention, warranting further mechanistic and in vivo evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, Faculty of Science and Technology, Universitas Islam Negeri (UIN) Sunan Kalijaga Yogyakarta, Yogyakarta 55281, Indonesia.
- Master's Program in Pharmaceutical Science, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
- Department of Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
- Department of Agricultural Sciences, University of Napoli Federico II, Piazza Carlo di Borbone 1, 80055 Portici, NA, Italy.
- Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131 Napoli, Italy.
- Master of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya 60286, Indonesia.
ORCID-Profile: Dhecella Winy Cintya Ningrum, Adha Fauzi Hendrawan, Lucia De Luca, Antonello Santini, Fahrul Nurkolis
Förderung
- Penelitian Inovasi Teknologi Program of UIN Sunan Kalijaga Yogyakarta
Zitieren
APA
Handayani, N., Ningrum, D. W. C., Hendrawan, A. F., Yuniati, A., Romano, R., De Luca, L., Santini, A., & Nurkolis, F. (2025). Integrative Metabolomics, Pharmacoinformatics and Experimental Studies Reveal the Neuroprotective Potential of Caulerpa racemosa Metabolites Against Alzheimer’s Disease. Marine Drugs, 23(12), 475. https://doi.org/10.3390/md23120475
Vancouver
Handayani N, Ningrum DWC, Hendrawan AF, Yuniati A, Romano R, De Luca L, et al. Integrative Metabolomics, Pharmacoinformatics and Experimental Studies Reveal the Neuroprotective Potential of Caulerpa racemosa Metabolites Against Alzheimer’s Disease. Marine Drugs. 2025;23(12):475. doi:10.3390/md23120475
BibTeX
@article{Handayani2025,
author = {Handayani, Nita and Ningrum, Dhecella Winy Cintya and Hendrawan, Adha Fauzi and Yuniati, Anis and Romano, Raffaele and De Luca, Lucia and Santini, Antonello and Nurkolis, Fahrul},
title = {Integrative Metabolomics, Pharmacoinformatics and Experimental Studies Reveal the Neuroprotective Potential of Caulerpa racemosa Metabolites Against Alzheimer’s Disease},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {12},
pages = {475},
doi = {10.3390/md23120475}
}
EUVIMED